Liraglutide, a glucagon-like peptide-1 receptor agonist, ameliorates inflammation and apoptosis via inhibition of receptor for advanced glycation end products signaling in AGEs induced chondrocytesXianyu Zhang, Guobao Wu|BMC Musculoskeletal Disorders|2024Cited by 26